Bacterial Disease Diagnostics Market Size

  • Report ID: 5206
  • Published Date: Sep 01, 2023
  • Report Format: PDF, PPT

Bacterial Disease Diagnostics Market Size

Bacterial Disease Diagnostics Market size is estimated to surpass USD 8 Billion by the end of 2035, witnessing around 8% CAGR during the forecast period i.e., 2023 – 2035. In the year 2022, the industry size of bacterial disease diagnostics was USD 3 Billion. The growth of the market can be attributed to the growing incidences of mass food poisoning. In the world, around 600 million fell ill due to the consumption of contaminated food and nearly 33 million lost their lives. Bacterial illness is a leading cause of food poisoning in humans. As consumers become increasingly worried about food safety, the demand for trustworthy bacterial illness diagnostics grows.

In addition to this, one aspect that is expected to drive the growth of the bacterial disease diagnostics market is rising research on new treatments and diagnoses. BARDA has collaborated with the government to help a number of companies research novel infectious disease medications. Ongoing research aids in the identification and description of new bacterial pathogens. Researchers can aid in the development of diagnostic tests for these novel infections, aiding disease control.


Bacterial Disease Diagnostics Market

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5206
  • Published Date: Sep 01, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of bacterial infection and technological advancement in diagnostic technology are the major factors driving the market growth.

The market size of bacterial disease diagnostics is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2023 – 2035.

The major players in the market are bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, and GENERI BIOTECH s.r.o.

The bacterial skin infection segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying